Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Prepaid Assets: 2009-2018

Historic Prepaid Assets for Fresenius Medical Care AG (FMS) over the last 17 years, with Sep 2025 value amounting to $707.6 million.

  • Fresenius Medical Care AG's Prepaid Assets fell 16.96% to $707.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $707.6 million, marking a year-over-year decrease of 16.96%. This contributed to the annual value of $717.9 million for FY2024, which is 59.73% down from last year.
  • As of Q3 2025, Fresenius Medical Care AG's Prepaid Assets stood at $707.6 million, which was up 10.72% from $639.1 million recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Prepaid Assets registered a high of $1.8 billion during Q4 2023, and its lowest value of $639.1 million during Q2 2025.
  • Over the past 3 years, Fresenius Medical Care AG's median Prepaid Assets value was $783.4 million (recorded in 2024), while the average stood at $926.4 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first surged by 89.09% in 2023, then plummeted by 59.51% in 2024.
  • Fresenius Medical Care AG's Prepaid Assets (MRQ) stood at $1.0 billion in 2021, then decreased by 6.44% to $937.7 million in 2022, then surged by 89.09% to $1.8 billion in 2023, then plummeted by 59.51% to $717.9 million in 2024, then decreased by 1.44% to $707.6 million in 2025.
  • Its Prepaid Assets was $707.6 million in Q3 2025, compared to $639.1 million in Q2 2025 and $665.4 million in Q1 2025.